Arkolith/Insider Trading/CLDI/Form 4

Leftwich Scott

DirectorCalidi Biotherapeutics, Inc. (CLDI) · full profile →Form 4 · filed Jan 4, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 21, 2023Grant(A)9K$1.80$16K470K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 21, 2023Grant(A)70K——70K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-001132) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML